Dasatinib Monohydrate

Dasatinib Monohydrate is used to treat people with chronic myeloid leukemia and people with acute lymphoblastic leukemia who are positive for the Philadelphia chromosome.Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia. Reference standards of Dasatinib Monohydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Dasatinib Monohydrate - API Standards 
    [catalogue_number] => PA 04 2280000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 506.02
    [form] => C22H28ClN7O3S
    [cas] => 863127-77-9
    [pslug] => 863127-77-9-dasatinib-monohydrate-pa042280000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 8
    [offers_name] => Ready Stock
    [offers_status] => 1
    [offers_start_date] => 2024-12-16
    [offers_end_date] => 2024-12-31
    [pageview] => 2
    [offers_slug] => ready-stock
    [offers_product_id] => 35202
    [offers_product_code] => PA 04 2280000
    [offers_master_id] => 8
    [offer_percentage] => 20 % OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards
)